Miyoko Ikejima
- Molecular Biology
- Oncology top 10%
- Pathology and Forensic Medicine top 5%
- Cancer Research top 10%
- Immunology
- Co-authors
- Takashi ShimadaEiitsu NakajimaD. Michael GillJosef JiricnyFabio PalomboIngram IaccarinoTakashi SügimuraMasanao Miwa
- Topics
- PARP inhibition in cancer therapy (10 papers)Genetic factors in colorectal cancer (9 papers)DNA Repair Mechanisms (6 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Miyoko Ikejima
20 papers receiving 758 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 580
- Oncology 386
- Pathology and Forensic Medicine 359
- Cancer Research 184
- Immunology 91
Countries citing papers authored by Miyoko Ikejima
This map shows the geographic impact of Miyoko Ikejima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyoko Ikejima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyoko Ikejima more than expected).
Fields of papers citing papers by Miyoko Ikejima
This network shows the impact of papers produced by Miyoko Ikejima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyoko Ikejima. The network helps show where Miyoko Ikejima may publish in the future.
Co-authorship network of co-authors of Miyoko Ikejima
This figure shows the co-authorship network connecting the top 25 collaborators of Miyoko Ikejima. A scholar is included among the top collaborators of Miyoko Ikejima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miyoko Ikejima. Miyoko Ikejima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 18 | |
| 4 | 15 | |
| 5 | 5 | |
| 6 | 6 | |
| 7 | 8 | |
| 8 | 304 | |
| 9 | 46 | |
| 10 | 14 | |
| 11 | 26 | |
| 12 | 18 | |
| 13 | 189 | |
| 14 | 18 | |
| 15 | 28 | |
| 16 | 25 | |
| 17 | 9 | |
| 18 | 29 | |
| 19 | The life history of poly(ADP-ribose). | 1 |
| 20 | 29 |
About Miyoko Ikejima
Miyoko Ikejima is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology, having authored 20 papers that have together received 790 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), Genetic factors in colorectal cancer (9 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (359 citations), Oncology (386 citations) and Cancer Research (184 citations). Miyoko Ikejima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Takashi Shimada, Eiitsu Nakajima, D. Michael Gill, Josef Jiricny, Fabio Palombo, Ingram Iaccarino, Takashi Sügimura, Masanao Miwa, Shigeru Noguchi and T. Ogura. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Current Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.